211 At-Labeled 5F7

N/A

Report date: 2025/11/21 17:15:33

Base Information

Drug Name211 At-Labeled 5F7

Drug Alias Name211 At-Labeled Anti-HER2 Single Domain Antibody Fragment 5F7

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragmentRadiation-emitting products > Nuclides > Astatine > 211AtBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody diagnostics +[6]

Mechanisms of ActionAnti-HER2

TargetsReceptor protein-tyrosine kinase erbB-2

Therapy Area/IndicationsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesDuke University

China Registration ClassN/A

Develop Information

Active CompaniesDuke University

Inactive CompaniesN/A

Active IndicationsBreast Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A